Cite
HARVARD Citation
Wils, P. et al. (2018). Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience. Alimentary pharmacology & therapeutics. 47 (5), pp. 588-595. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wils, P. et al. (2018). Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience. Alimentary pharmacology & therapeutics. 47 (5), pp. 588-595. [Online].